The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting – (Eye 30, 958 (July 2016))

7 July 2016

This news item is available to RCOphth members only, please log in below to access.